Tenaya Therapeutics (TNYA) Total Liabilities (2020 - 2026)

Tenaya Therapeutics has reported Total Liabilities for 7 years, with the latest figure at $28.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 17.61% year-over-year to $28.9 million; the trailing twelve-month figure through Mar 2026 stood at $28.9 million (up 17.61% YoY), and the FY2025 full-year result was $23.7 million, down 12.66% from the prior year.
• Total Liabilities for Q1 2026 stood at $28.9 million, up from $23.7 million in the prior quarter.
• The five-year high for Total Liabilities was $35.6 million in Q4 2022, with the low at $22.1 million in Q3 2025.
• Average Total Liabilities over 5 years is $28.4 million, with a median of $28.9 million recorded in 2026.
• Peak annual rise in Total Liabilities reached 29.83% in 2022, while the deepest fall reached 65.51% in 2022.
• Tracing TNYA's Total Liabilities over 5 years: stood at $35.6 million in 2022, then slipped by 12.59% to $31.1 million in 2023, then declined by 12.88% to $27.1 million in 2024, then fell by 12.66% to $23.7 million in 2025, then rose by 22.09% to $28.9 million in 2026.
• The last three Total Liabilities figures came in at $28.9 million (Q1 2026), $23.7 million (Q4 2025), and $22.1 million (Q3 2025), per Business Quant data.

Peer Comparison